BIOCRYST PHARMACEUTICA
7.7800
08-November-24 14:59:59
15 minutes delayed
Stocks
+0.1100
+1.43%
Today's range
7.5200 - 7.8400
ISIN
N/A
Source
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jul 2023 06:00:12 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jun 2023 06:00:42 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
01 Jun 2023 06:00:45 By Nasdaq GlobeNewswire
-
31 May 2023 06:02:04 By Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Public Health Institute of Chile
22 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2023 15:01:01 By Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
03 May 2023 06:00:55 By Nasdaq GlobeNewswire
-
27 Apr 2023 06:00:01 By Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2023 Financial Results on May 3
19 Apr 2023 06:00:27 By Nasdaq GlobeNewswire
-
BioCryst Refinances Existing Debt with $450 Million Financing Commitment from Pharmakon
18 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
12 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Apr 2023 06:00:36 By Nasdaq GlobeNewswire
-
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
31 Mar 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success
29 Mar 2023 15:01:31 By Nasdaq GlobeNewswire
-
08 Mar 2023 14:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Mar 2023 06:00:13 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
22 Feb 2023 06:00:04 By Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones
21 Feb 2023 06:00:23 By Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2022 Financial Results on February 21
07 Feb 2023 06:00:16 By Nasdaq GlobeNewswire